Showing 3221-3230 of 6035 results for "".
- Bausch + Lomb Receives 510(k) Clearance For Use Of The Tangible Hydra-PEG Custom Contact Lens Coatinghttps://modernod.com/news/bausch-lomb-receives-510k-clearance-for-use-of-the-tangible-hydra-peg-custom-contact-lens-coating-on-several-lenses/2476297/Bausch + Lomb announced it has received 510(k) clearance for use of the Tangible Hydra-PEG custom contact lens coating technology with some of its leading Boston gas permeable (GP) materials, the Boston XO, Boston XO2, Boston EO, and Boston ES lenses, including th
- Neurotech Pharmaceuticals Granted Fast Track Designation from the FDA for the Treatment of Macular Telangiectasia Type 2https://modernod.com/news/neurotech-pharmaceuticals-granted-fast-track-designation-from-the-fda-for-the-treatment-of-macular-telangiectasia-type-2/2476300/Neurotech Pharmaceuticals announced that the FDA has granted Fast Track designation for the company’s development candidate, NT-501 or Renexus, for the treatment of macular telangiectasia type 2 (MacTel). Fast track is a designation by the FDA to facilitate the development and expedite the
- Our Artificial Cornea Breakthrough Could Lead to Self-Assembling Organshttps://modernod.com/news/our-artificial-cornea-breakthrough-could-lead-to-self-assembling-organs/2476305/For every person in the world who receives a cornea transplant, there are 69 others who still need one. That leaves about 12.5m people with limited sight because there aren’t enough eye donors. But what if we cou
- GenSight’s Gene Therapy GS010 Fails Second Late-Stage Leber Hereditary Optic Neuropathy Studyhttps://modernod.com/news/gensights-gene-therapy-gs010-fails-second-late-stage-leber-hereditary-optic-neuropathy-study/2476321/GenSight Biologics announced that a phase 3 study investigating a single injection of the experimental gene therapy GS010 failed to improve vision loss compared to sham treatment in patients with 11778-ND4 Leber hereditary optic neuropathy (LHON). In the RESCUE study, patients with
- Silgan to Debut Iridya Preservative-Free Multi-dose Eye Dropperhttps://modernod.com/news/silgan-to-debut-iridya-preservative-free-multi-dose-eye-dropper/2476322/Silgan Dispensing will highlight its newest ophthalmic dispensing solution, Iridya, at this year’s Pharmapack, Europe’s dedicated pharmaceutical packaging and drug delivery event. Iridya is a next-generation, preservative-free multi-dose, eye dropper that improves on existing technology by
- Zeiss Develops Multifunctional Smart Glasshttps://modernod.com/news/zeiss-develops-multifunctional-smart-glass/2476327/For the first time, a technology developed by Zeiss has made it possible to utilize transparent glass or plastic in a whole range of different ways, according to a company news release. The see-through surfaces with integrated, invisible microstructured optics permit a range of different applicat
- Bausch + Lomb Introduces Zen Multifocal Scleral Lens for Presbyopiahttps://modernod.com/news/bausch-lomb-introduces-zen-multifocal-scleral-lens-for-presbyopia/2476173/Bausch + Lomb announced the introduction of the Zen multifocal scleral lens for presbyopia, which will be exclusively available with Zenlens and Zen RC scleral lenses through the company’s specialty vision products unit. This innovation will allow eye care professionals to fit presbyopic patients
- Aerie Pharmaceuticals Announces Acceptance of Its Investigational NDA for AR-1105 (Dexamethasone Intravitreal Implant)https://modernod.com/news/aerie-pharmaceuticals-announces-acceptance-of-its-investigational-nda-for-ar-1105-dexamethasone-intravitreal-implant/2476183/Aerie Pharmaceuticals announced that the FDA has reviewed the investigational new drug application (IND) for AR-1105 (dexamethasone intravitreal implant) and it is now in effect, allowing Aerie to initiate human studies in the treatment of macular edema due to retinal vein occlusion (RVO). The IN
- Johnson & Johnson Vision Launches the UK’s First Free Nationwide Recycling Program for all Contact Lenseshttps://modernod.com/news/johnson-johnson-vision-launches-the-uks-first-free-nationwide-recycling-program-for-all-contact-lenses/2476189/Johnson & Johnson Vision has launched the Acuvue Contact Lens Recycle Program, the UK’s first free nationwide program that enables consumers to easily recycle their contact lenses and the blister and foil packaging after use. The program is available to all soft contact lens wearers reg
- US Democratic Lawmakers Introduce Bills Targeting Drug Pricinghttps://modernod.com/news/us-democratic-lawmakers-introduce-bills-targeting-drug-pricing/2476197/US lawmakers including Senator Bernie Sanders and Representative Elijah Cummings introduced legislation on Thursday seeking to reduce prescription drug prices. “The United States pays by far the highest prices in the world for prescription drugs,” Sen. Sanders commented, adding “